Women’s healthcare company TherapeuticsMD (NASDAQ:TXMD) announced Tuesday that it reached an agreement to be acquired by an affiliate of private equity firm EW Healthcare Partners for $10 per share in an all-cash transaction.
TherapeuticsMD (TXMD) shares have added ~351% in the pre-market on the news.
Per the terms, EW Healthcare Partners is set to start a tender offer to acquire all outstanding shares of TXMD common stock at the agreed purchase price, immediately followed by a merger.
The buyout offer worth about $177M, including debt, represents a premium of 367.3% over the closing price of TherapeuticsMD (TXMD) shares on Friday.
The transaction is expected to close on or before July 13, 2022, subject to certain conditions.